Physician profile
Shawn Putman
NPI 1174586507
$4,472.80
in general payments reported to CMS, 2019-2025
21 companies · $843 in 2025
The $843 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $181 · 2021: $422 · 2022: $1,757 · 2023: $578 · 2024: $521 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,931 · Education: $10.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,931.06 |
| Education | $10.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $1,269.15 | 2022 | |
| Alcon Vision LLC | $669.62 | 2022-2025 | Hydrus Microstent, Tryptyr, Rocklatan |
| Mallinckrodt Hospital Products INC. | $526.27 | 2020-2025 | Acthar |
| Bausch & Lomb Americas INC. | $480.53 | 2022-2025 | Vyzulta, Lotemax Sm, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $343.10 | 2019-2021 | |
| Abbvie INC. | $257.35 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $240.93 | 2024-2025 | Tecnis Simplicity |
| Allergan, INC. | $163.43 | 2019-2022 | |
| Glaukos Corporation | $143.56 | 2023-2024 | Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Iaccess Precision Blade, Idose |
| Harrow Eye, LLC | $62.24 | 2023-2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $53.88 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $49.44 | 2021 | |
| Sight Sciences, INC. | $44.74 | 2024 | Omni Surgical System |
| Akorn Operating Company LLC | $30.13 | 2021 | |
| Thea Pharma INC. | $25.67 | 2025 | Iyuzeh |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $21.80 | 2024 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $19.04 | 2024 | Xdemvy |
| Dompe US, INC. | $18.11 | 2022 | |
| Merz Pharmaceuticals, LLC | $18.06 | 2025 | Xeomin |
| Novartis Pharmaceuticals Corporation | $16.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Putman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.